1154 related articles for article (PubMed ID: 30423609)
21. Primary sclerosing neuroendocrine carcinomas of the lung: A clinicopathologic and immunohistochemical study of 10 cases.
Kalhor N; Suster S; Moran CA
Am J Clin Pathol; 2010 Apr; 133(4):618-22. PubMed ID: 20231615
[TBL] [Abstract][Full Text] [Related]
22. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis.
Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A
Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601
[TBL] [Abstract][Full Text] [Related]
23. [Pigmented microcystic chromophobe renal cell carcinoma: a clinicopathologic analysis of five cases].
Zhao M; Wang YB; Zhang Q; Jin L; Yang ZR; Zhang X; Ru GQ; Zhang DH; He XL
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):926-930. PubMed ID: 30522173
[No Abstract] [Full Text] [Related]
24. [Clinicopathologic features of combined hepatic carcinoma].
He C; Yin HF; Liu P; Zhang Y; Zhang JB
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101
[TBL] [Abstract][Full Text] [Related]
25. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine carcinomas of the uterine cervix: A clinicopathological study.
Sitthinamsuwan P; Angkathunyakul N; Chuangsuwanich T; Inthasorn P
J Med Assoc Thai; 2013 Jan; 96(1):83-90. PubMed ID: 23720983
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.
Yazawa T
Pathol Int; 2015 Jun; 65(6):277-85. PubMed ID: 25708144
[TBL] [Abstract][Full Text] [Related]
29. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.
Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP
Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848
[TBL] [Abstract][Full Text] [Related]
30. Renal neuroendocrine tumours: a clinicopathological study.
Lane BR; Chery F; Jour G; Sercia L; Magi-Galluzzi C; Novick AC; Zhou M
BJU Int; 2007 Nov; 100(5):1030-5. PubMed ID: 17784891
[TBL] [Abstract][Full Text] [Related]
31. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases.
Baker PM; Oliva E; Young RH; Talerman A; Scully RE
Am J Surg Pathol; 2001 May; 25(5):557-68. PubMed ID: 11342766
[TBL] [Abstract][Full Text] [Related]
32. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
33. Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings.
Jeung JA; Cao D; Selli BW; Clapp WL; Oliai BR; Parwani AV; Allan RW
Hum Pathol; 2011 Oct; 42(10):1554-61. PubMed ID: 21496872
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine marker staining pattern categorization of small-sized pulmonary large cell neuroendocrine carcinoma.
Minami K; Tanaka Y; Ogawa H; Jimbo N; Nishio W; Yoshimura M; Itoh T; Maniwa Y
Thorac Cancer; 2019 Nov; 10(11):2152-2160. PubMed ID: 31583856
[TBL] [Abstract][Full Text] [Related]
35. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients.
Shin SJ; DeLellis RA; Ying L; Rosen PP
Am J Surg Pathol; 2000 Sep; 24(9):1231-8. PubMed ID: 10976697
[TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
37. Renal carcinoid tumor: a clinicopathologic study of 21 cases.
Hansel DE; Epstein JI; Berbescu E; Fine SW; Young RH; Cheville JC
Am J Surg Pathol; 2007 Oct; 31(10):1539-44. PubMed ID: 17895755
[TBL] [Abstract][Full Text] [Related]
38. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
[TBL] [Abstract][Full Text] [Related]
39. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the parotid gland: report of three cases with contemporary review of salivary neuroendocrine carcinomas.
Said-Al-Naief N; Sciandra K; Gnepp DR
Head Neck Pathol; 2013 Sep; 7(3):295-303. PubMed ID: 23456649
[TBL] [Abstract][Full Text] [Related]
40. SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors.
Yu L; Dong Y; Xue J; Xu S; Wang G; Kuang D; Duan Y
Diagn Pathol; 2022 Jan; 17(1):2. PubMed ID: 34996493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]